Claudio De Felice, MD, Endocrine and Metabolism Research Laboratory, National Children’s Medical Research Center, 3-35-31 Taishido, Setagaya-ku, Tokyo 154 (Japan) Dear Sir, Biotinidase (EC 3.5.1.12) is a multiple hydrolase which mainly hydrolyses biotinyl-amido compounds, such as biocytin [1], bio-tinyl-4-aminobenzoate [2] and biotinyl-6aminoquinoline (BAQ) [3]. Although detectable biotinidase activity has been reported in most mammalian tissues and body fluids [4], no enzyme activity in the human urine has been reported to date. Recently, a highly sensitive and specific HPLC-fluorimetric method for a biotinidase assay with BAQ as substrate has been developed by us [5] and subsequently applied to the enzyme determination in the cerebrospi-nal fluid [6]. Using a similar method, biotinidase activity has been detected in the urine of the majority (19/25 = 76%) of patients with renal disease associated with protein-uria, whereas it was non-detectable in 40 healthy, ageand sexmatched Japanese controls [7]. In the present study, the investigation on the biotinidase activity in the urine was extended to healthy non-Japanese individuals. A total of 24 subjects (12 male, 12 female; mean age 25.9 years, range 3.7-44 years) was selected for the present study. The participants were originally from Russia (n = 12), Italy (n = 3), the Czech Republic (n = 3), China (n ≈ 2) the USA (n = 1), South Korea (n = 1), Hungary (n = 1) and Germany (n = 1). At the time of the study, the subjects had been living in Japan, for an average of 15 months (range 1-84 months). The healthy state was ascertained on the basis of a clinical work-up including detailed history, physical examination and standard laboratory tests on blood and urine. The participants were not receiving drugs known to affect the biotin metabolism. Informed consent for the study was obtained. Random, as well as 24-hour urine samples were collected. A 200-μl volume of fresh urine from each sample was filtered (Eki-crodisc 13, pore size 0.2 μm; Gelman Sciences, Japan) and stored at -80°C until the date of the assay. Biotinidase activity using BAQ as enzyme substrate was determined by the HPLCfluorimetric assay, as previously described [5-7]. Enzyme activity was expressed both as pmol·min_1·ml_1 (activity per volume) and pmol·min^·mg-1 of protein (specific activity). Mean intraand in-terassay coefficients of variation were 1.2 and 2.6%, respectively. Urine
[1]
C. De Felice,et al.
Changes in cerebrospinal fluid biotinidase activity in Staphylococcus aureus meningitis.
,
1994,
Brain & development.
[2]
K. Yamauchi,et al.
Improved high-performance liquid chromatographic determination of biotinidase activity with biotinyl-6-aminoquinoline as substrate.
,
1993,
Journal of chromatography.
[3]
K. Dakshinamurti,et al.
Purification and characterization of human serum biotinidase.
,
1986,
The Journal of biological chemistry.
[4]
K. Bartlett,et al.
A sensitive fluorimetric rate assay for biotinidase using a new derivative of biotin, biotinyl-6-aminoquinoline.
,
1984,
Analytical biochemistry.
[5]
J. Pispa.
Animal biotinidase.
,
1965,
Annales medicinae experimentalis et biologiae Fenniae.
[6]
W. P. Boger,et al.
Biocytinase, an Enzyme Concerned with Hydrolytic Cleavage of Biocytin
,
1954,
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.